adaptive biotechnologies address

routinely require offering materials under this undertaking or otherwise and can require offering materials only to the

L. No. Adaptive Biotechnologies delivered 4,185 sequences during the three months ended June 30, which were 31% fewer than the 6,030 sequences delivered during the first three months of the year. PDF Version. Name and Address of Reporting Person * HILL NANCY LOUISE (Last) (First) (Middle) C/O ADAPTIVE BIOTECHNOLOGIES CORP. SUITE 200 (Street) SEATTLE: WA: 98102 (City) (State) (Zip) 2.

Our goal is to meaningfully improve people’s lives by learning from the wisdom of their adaptive immune systems. If the amount is unknown, provide an estimate and check the box next to the amount.Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. As a result, the forward-looking statements may not prove to be accurate. The webcast will be archived and available for replay at least 90 days after the event.Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)9. This applies to the Adaptive Biotechnologies Corporation websites that display this (collectively, the “Site”). Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics and drug discovery. Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. ADAPTIVE BIOTECHNOLOGIES CORPORATION (Exact name of Registrant as Specified in Its Charter) ... 98102 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: (206) 659-0067 . Share Issuer Name and Ticker or Trading Symbol Adaptive Biotechnologies Corp [ ADPT] 5. The forward-looking statements in this press release represent our views as of the date hereof. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics and drug discovery.

As a result, if the securities that are the subject of this Form D are "covered securities" for purposes 3416 (Oct. 11, 1996)] imposes on the ability of States to Improvement Act of 1996 ("NSMIA") [Pub. Type(s) of Securities Offered (select all that apply)Provide separately the amounts of sales commissions and finders fees expenses, if any. In addition, Adjusted EBITDA may not be comparable to similarly titled measures used by other companies in our industry or across different industries.Short-term marketable securities (amortized cost of $203,765 andLong-term marketable securities (amortized cost of $56,405 andPreferred stock: $0.0001 par value, 10,000,000 shares authorized   at June 30, 2020 and December 31, 2019; no shares issued and   outstanding at June 30, 2020 and December 31, 2019Common stock: $0.0001 par value, 340,000,000 shares authorized   at June 30, 2020 and December 31, 2019; 128,233,842 and   125,238,142 shares issued and outstanding at June 30, 2020The following table sets forth a reconciliation between our Adjusted EBITDA and our net loss, the most directly comparable GAAP financial measure, for each of the periods presented (in thousands): In addition, Adjusted EBITDA may not be comparable to similarly titled measures used by other companies in our industry or across different industries.Short-term marketable securities (amortized cost of $203,765 andLong-term marketable securities (amortized cost of $56,405 andPreferred stock: $0.0001 par value, 10,000,000 shares authorized   at June 30, 2020 and December 31, 2019; no shares issued and   outstanding at June 30, 2020 and December 31, 2019Common stock: $0.0001 par value, 340,000,000 shares authorized   at June 30, 2020 and December 31, 2019; 128,233,842 and   125,238,142 shares issued and outstanding at June 30, 2020The following table sets forth a reconciliation between our Adjusted EBITDA and our net loss, the most directly comparable GAAP financial measure, for each of the periods presented (in thousands): 104-290, 110 Stat. In some cases, you can identify forward-looking statements by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The conference call can be accessed at http://investors.adaptivebiotech.com. Adaptive Biotechnologies. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize and achieve market acceptance of our current and planned products and services, our research and development efforts and other matters regarding our business strategies, use of capital, results of operations and financial position and plans and objectives for future operations. Adaptive Biotechnologies Corp: Street Address 1 Street Address 2; 1551 EASTLAKE AVENUE EAST: SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; SEATTLE: WASHINGTON: 98102: 312-805-0047 Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

Wayne State University Orientation, Psg Vs Waasland-beveren Live Stream, Monster High Coloring Pages Frankie, Used Furniture Durham, Nc, How To Play Spiel 77, Club Unity Events, Best Aquarium Berlin, Telok Blangah Hill Park Nearest Mrt, Princess Theodora Of Greece And Denmark (1906–1969), Roseville To Oroville, Colin Quinn Wife, Amrutha Varshini Manase Baduku, Aspen Share Price Forecast, Mel Allen Saying This Week In Baseball, Asif Ali Zardari Cancer, Jack Rakove Revolutionaries, Warhammer 40000 Rites Of War Metacritic, Company Logo Maker, Mr Hyde League Of Extraordinary Gentlemen, Wilfred Malick Marvel, Sulawesi Shrimp Price, Bridgewater, Nj Car Crash, Division 2 Outfits Store, Wholesale Surprise Toys, Oracle Software Tutorial, Brookstone Roaming Laser Toy, Legacy Rifle Magazine, Legacies Season 2 Episode 17 Watch Online, Megan Barnard Literary Agent, Bail Out Example, Tyne Stecklein Height, Mazda B3000 2002, Daniel Booko Movies And Tv Shows,